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INTRODUCTION
Pleural involvement is an uncom-
mon but well recognized compli-
cation of chronic pancreatitis [1], 
mainly in the form of pleural effu-
sion affecting the left hemithorax. 
Pancreatic pseudocyst extending 
to the posterior mediastinum with 
or without communication with 
the pleural space is another rare 
form of this involvement.
The treatment of chronic pancre-
atic pleural effusions and pancre-
atic pseudocysts generally starts 
with a conservative approach in-
cluding bowel rest, drainage of 
the pleural effusion by repeated 
thoracentesis or a chest tube, and 
total parenteral nutrition (TPN) for 
a period of time determined by the 
clinical course. Other treatment 
modalities including percutane-
ous drainage, endoscopic retro-
grade cholangiopancreatogram 
(ERCP) with stenting of the pan-
creatic duct and surgical drain-
age are used if conservative ap-
proaches fail.
We report a patient with a com-
plicated pancreatic pseudocyst 
who showed an involvement of 
the posterior mediastinum and 
right pleural space, with conspec-
tus sparing of the left hemithorax. 
The patient had a prolonged and Libyan Journal of Medicine, Volume 1, 2006
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complicated course that includ-
ed recurrence of the pseudocyst 
with oral feedings and the devel-
opment of a splenic artery aneu-
rysm. Some of the above ﬁndings 
have been reported separately 
as uncommon complications of 
chronic pancre-
atitis and pan-
creatic pseud-
cyst, but to our 
knowledge a 
single case with 
all these compli-
cations was not 
published in the 
English litera-
ture.
CASE REPORT
A 42-year-old 
male with history 
of alcohol abuse 
and pancreati-
tis, presented to Kino Commu-
nity Hospital outpatient clinic with 
complaints of chest discomfort 
and shortness of breath over a 
two-week period. At presentation 
the patient was in no distress and 
had normal vital signs. The chest 
examination revealed decrease 
in air movement over the right 
hemithorax and the abdominal 
examination demonstrated mild 
epigastric tenderness.
A chest x-ray showed a large right 
pleural effusion and an epigastric 
shadow resembling a hiatal her-
nia (ﬁgure 1). A computed axial 
tomography scan (CAT scan) 
showed a right pleural effusion 
and a posterior mediastinal pseu-
do cyst (ﬁgure 2).   
Figure 1: Chest X-ray of the right pleu-
ral effusion. 
Laboratory investigations re-
vealed the following; serum amy-
lase 556 units, pancreatic iso-
enzyme 365 units, Lipase 143 
units, total protein 5.9 mg/dL, 
total bilirubin 0.7mg/dL, albumin 
2.4 mg/dL, alkaline phosphatase 
75 IU/L, AST 68 IU/L, ALT 95 IU/
L. Thoracentesis was performed 
and 1500cc of bloody effusion     www.ljm.org.ly   
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was aspirated; WBC 2200 / cubic 
mm, RBC 16500 / cubic mm, LDH 
1061 IU/L, protein 4300 mg/ dl, 
and amylase 22700,  AFB smear 
and cultures were negative.
The day after thoracentesis a 
chest x-ray revealed rapid re-ac-
cumulation of the pleural effusion. 
The patient was hospitalized; 
chest tube was inserted in the 
right pleural space and he was 
started on TPN. The following day 
the patient’s symptoms resolved 
and the chest x-ray demonstrated 
complete resolution of the pleural 
effusion. 
A week later the asymptomatic 
patient had a CAT scan, which 
demonstrated continued resolu-
tion of the effusion and resolved 
pseudocyst. The chest tube out-
put ceased, however, the serum 
amylase and lipase continued to 
be elevated.
Figure 2: CAT scan of the right pleu-
ral effusion and posterior mediastinal 
pseudo cyst.
Brief oral feeding started on day 
ten followed by re-accumulation 
of the pleural ﬂuid (ﬁgures 2&3). 
The patient continued on TPN 
and made non per os (NPO), Oc-
teriotide acetate (Sandostatin, 
Novartis Pharmaceutical) was 
started to decrease pancreatic 
output. The chest tube was re-
moved a few days later. Libyan Journal of Medicine, Volume 1, 2006
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Figure 3: CAT scan of the abdominal 
view of the pancreatic pseudo cyst. 
 
Three months later the serum 
amylase was still elevated 400 
IU/L, but the patient was asymp-
tomatic and a repeat CAT scan 
of the chest showed no effusion 
or pseudocyst. Oral feeding was 
attempted which again led to re-
accumulation of the pleural effu-
sion. The patient again was made 
NPO/TPN and was scheduled for 
surgical drainage. Prior to surgery 
the patient developed severe ab-
dominal pain and was found to 
be acutely anemic (Hemoglobin 
6.5g/dl). An emergent splenic ar-
tery angiogram revealed a bleed-
ing splenic artery aneurysm (ﬁg-
ure 4). 
  
The patient underwent splenic 
artery embolization followed by 
splenectomy and cystoenteric 
drainage procedure in a later 
date. One year later the patient is 
asymptomatic with normal labo-
ratory and radiological ﬁndings. 
DISCUSSION
Pancreatic pleural effusion can 
complicate both acute and chron-
ic pancreatitis. The former usually 
leads to a small sympathetic effu-
sion, mainly involving the left side 
and is usually self-limiting [15]. 
Chronic pancreatitis may lead to 
an internal pancreatic ﬁstula with 
leakage of pancreatic secretions     www.ljm.org.ly   
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anteriorly to the peritoneal sac 
forming pancreatic ascites, or 
posteriorly to the retroperitoneal 
space forming a pseudocyst [2]. 
Rarely pseudocyst can dissect 
through the aortic or esophageal 
hiatus into the posterior mediasti-
num and present as a mediasti-
nal pseudocyst. 
Figure 4: Angiogram of the splenic ar-
tery aneurysm.
Pancreatic pleural effusions are 
caused either by a pancreatico-
pleaural ﬁstula passing through 
an opening in the diaphragm [2], 
or a mediastinal pseudocyst that 
has ruptured or extended into the 
pleura cavity [3]. Chronic pleural 
effusion is uncommon but a well 
recognized complication of chron-
ic pancreatitis [1].  The majority of 
cases occur in men with a history 
of alcoholism [5]. The effusions 
are usually massive and left sid-
ed with high amylase levels, while 
serum amylase levels may only 
be mildly elevated  [5, 6]. Clini-
cal presentation is 
variable and often 
misleading, contrib-
uting to increased 
morbidity and mor-
tality [4]. Pulmonary 
symptoms are more 
frequent than ab-
dominal symptoms, 
with dyspnoea be-
ing the most com-
mon complaint. 
The initial manage-
ment of pancreatic 
pleural effusion is 
usually medical with 
bowel rest, drainage 
of the pleural space by repeated 
thoracentesis or a chest tube and 
TPN.  Sandostatin, a long-act-
ing somatostatin analogue, is oc-
casionally added as part of the 
treatment for chronic pancreatic 
effusion [8, 9]. The favorable re-
sponse to medical treatment is 
variable ranging between 40%- Libyan Journal of Medicine, Volume 1, 2006
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60% in some reports [1, 5]. Fail-
ure of medical treatment is usually 
followed by several other modali-
ties depending on the clinical situ-
ation and the radiological feature 
of the effusion and pseudocyst.
Åke Andren-Sandberg and Chris-
tos Devenis [15, 16], performed 
an exhaustive literature search 
in their review of the natural his-
tory and treatment of pancreatic 
pseudocyst. They pointed out the 
conﬂicting information regarding 
the natural history of pancreatic 
pseudocyst. The pathology of duct 
involvement is also considered a 
main factor in treatment selection; 
however, ERCP is not practical in 
all cases, and MRCP is not read-
ily available. This makes evalua-
tion of different treatment options 
difﬁcult. Moreover, the selection 
of treatment is complicated by the 
high rate of spontaneous resolu-
tion of pseudocyst following the 
conservative approach.
Percutaneous drainage of the 
pseudocyst is an attractive ap-
proach that might circumvent an 
extensive surgical procedure if 
the pseudocyst is accessible [10]. 
ERCP with stent placement into 
the pancreatic duct to bridge the 
site of leakage can be used with 
success after the initial failure of 
medical management [11]. 
Surgical cystoenteric drainage is 
the ultimate procedure [12]; how-
ever, surgical drainage is techni-
cally difﬁcult if done early in the 
disease course since the pseudo-
cyst has no real boundaries and 
the pseudocyst wall in general is 
shaggy and frail [14].
Splenic artery aneurysm is a rare 
but frequently fatal complication of 
chronic pancreatitis. It is thought 
that the pancreatic secretions in 
contact with the splenic vessels 
may lead to the aneurysm forma-
tion. The treatment of such com-
plication is usually surgical resec-
tion with or without initial arterial 
embolization in actively bleeding 
high-risk patients [13].
In our case the medical manage-
ment was initially successful in 
resolving the effusion completely 
but the challenge was the per-
sistent elevated amylase and the 
recurrence of effusion with trials 
of oral feeding. The pseudocyst 
was not accessible for percutane-
ous drainage, and it was felt that 
ERCP with placement of pancre-
atic duct stent if failed to resolve 
the pseudocyst carry the risk of in-
troducing infection that may lead 
to urgent need for surgery, which 
is not advised early in the course 
of the pseudocyst formation.    www.ljm.org.ly   
page
71
Libyan Journal of Medicine, Volume 1, 2006
ljm
The patient’s reluctance to con-
sent for a procedure that may 
lead to surgical intervention, the 
dilemma created by the course 
of his disease, and the literature 
reports of high incidence of spon-
taneous resolution, all inﬂuenced 
the relatively long period of con-
servative measures.
CONCLUDING REMARKS
Chronic pancreatitis and pan-
creatic pseudocyst may lead to 
pulmonary complications with 
signiﬁcant morbidity and mortal-
ity. Early diagnosis and treatment 
with careful follow up is important 
to avoid unfavorable outcomes. 
Also, careful assessment of differ-
ent treatment options and choos-
ing the appropriate option on a 
case-to-case bases is paramount 
in the management of these com-
plications. 
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